SCHEMBL10037145

SCHEMBL10037145

O=C1C=C(N2CCNCC2)c2ccccc2C1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 1/20 0.77
NSD2 O96028 3/20 0.71
HKDC1 Q2TB90 3/20 0.71
APAF1 O14727 2/20 0.71
TDP2 O95551 2/20 0.71
MEN1 O00255 1/20 0.67
NPC1 O15118 1/20 0.67
RAB9A P51151 1/20 0.67
GALK1 P51570 1/20 0.67
BLM P54132 1/20 0.67
KMT2A Q03164 1/20 0.67
ATM Q13315 1/20 0.67
NOD2 Q9HC29 1/20 0.67
ATG4B Q9Y4P1 1/20 0.67
HTR7 P34969 3/20 0.44
HTR6 P50406 2/20 0.44
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.44
HTR5A P47898 1/20 0.44
ADRB1 P08588 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL246623 0.88 DNMT1 (0.59) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL7260223 0.83 APAF1 (1.00) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL30601628 0.80 APAF1 (1.00) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL4649553 0.80 DNMT1 (0.83) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL4647391 0.80 APAF1 (1.00) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL4876610 0.72 APAF1 (0.74) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL31290245 0.72 APAF1 (0.74) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL10556309 0.71 HTR7 (0.50) NSD2APAF1TDP2MEN1NPC1
SCHEMBL249168 0.70 APAF1 (0.77) DNMT1NSD2HKDC1APAF1TDP2
SCHEMBL31290115 0.70 APAF1 (0.77) DNMT1NSD2HKDC1APAF1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022070-A1 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use EMORY UNIVERSITY (US) 2012-01-26 US disclosed
US-20120022070-A1 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use EMORY UNIVERSITY (US) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022070-A1 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use HSP90AB1, HSP90AA1, HSP90AB2P DNMT1 4257/4885NSD2 4199/4885HKDC1 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.